Analytical challenges and solutions in doping control: a perspective from the Swedish Doping Control Laboratory

Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis.

Drug testing and analysis·2026

Lomerizine M6-An Important Urinary Metabolite in Anti-Doping Control Analysis for Correct Detection of Trimetazidine Abuse in Both Females and Males.

Drug testing and analysis·2026

Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application.

Drug testing and analysis·2025

Steroid anabolic and catabolic hormones in highly and recreationally trained female athletes across the menstrual cycle.

Physiological reports·2025

Evaluating the Early Operational Performance of the Endocrine Module in the Athlete Biological Passport.

Drug testing and analysis·2025

Analysis of Testosterone Esters in Serum and DBS Samples-Results From an Interlaboratory Study.

Drug testing and analysis·2025

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Bioanalysis·2026

Highlights from the 17th Japan Bioanalysis Forum Symposium.

Bioanalysis·2026

Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies.

Bioanalysis·2026

Development of an electrochemiluminescence-based bridging assay to detect antibodies against a PTH inverse agonist in human plasma.

Bioanalysis·2026

Advanced assay design for characterizing anti-drug antibody responses in clinical serum samples.

Bioanalysis·2026

Development and validation of a LC-MS/MS method for the quantification of the E-type prostanoid receptor 4 antagonist HTL0039732 in human plasma, for a Phase I/IIa clinical trial.

Bioanalysis·2026

When left isn't right: A case series of wrong-sided nerve blocks reported to webAIRS.

Anaesthesia and intensive care·2026

Detection of prohibited drugs in blood samples using spray mass spectrometry on plasma-treated paper.

Analytical and bioanalytical chemistry·2026

CRISPR/Cas12a and CHA-based SERS platform for ultrasensitive nucleic acid detection.

Analytica chimica acta·2026

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Making every test count: Insights from a test kit efficiency audit.

African journal of laboratory medicine·2026

Neutral-pH Cu-Lcys nanozymes for colorimetric detection of ascorbic acid under physiological conditions.

Analytical methods : advancing methods and applications·2026

Related Experiment Videos

Analytical challenges and solutions in doping control: a perspective from the Swedish Doping Control Laboratory

Related Concept Videos

Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis.

Lomerizine M6-An Important Urinary Metabolite in Anti-Doping Control Analysis for Correct Detection of Trimetazidine Abuse in Both Females and Males.

Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application.

Steroid anabolic and catabolic hormones in highly and recreationally trained female athletes across the menstrual cycle.

Evaluating the Early Operational Performance of the Endocrine Module in the Athlete Biological Passport.

Analysis of Testosterone Esters in Serum and DBS Samples-Results From an Interlaboratory Study.

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application.

Highlights from the 17th Japan Bioanalysis Forum Symposium.

Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies.

Development of an electrochemiluminescence-based bridging assay to detect antibodies against a PTH inverse agonist in human plasma.

Advanced assay design for characterizing anti-drug antibody responses in clinical serum samples.

Development and validation of a LC-MS/MS method for the quantification of the E-type prostanoid receptor 4 antagonist HTL0039732 in human plasma, for a Phase I/IIa clinical trial.

When left isn't right: A case series of wrong-sided nerve blocks reported to webAIRS.

Detection of prohibited drugs in blood samples using spray mass spectrometry on plasma-treated paper.

CRISPR/Cas12a and CHA-based SERS platform for ultrasensitive nucleic acid detection.

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.

Making every test count: Insights from a test kit efficiency audit.

Neutral-pH Cu-Lcys nanozymes for colorimetric detection of ascorbic acid under physiological conditions.

Related Experiment Videos

Analytical challenges and solutions in doping control: a perspective from the Swedish Doping Control Laboratory

Related Concept Videos

Related Articles